Finally, successful interventions to ameliorate cutaneous infestations

References

• Pearson ML, Selby JV, Katz KA, et al. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One. 2012;7(1):1. doi:10.1371/journal.pone.0029908.
   Web of Science ®Google Scholar
• Amaral L, Viveiros M, Molnar J. Antimicrobial activity of phenothiazines. In Vivo. Nov-Dec 2004;18(6):725–3.
   PubMed Web of Science ®Google Scholar
• Caldara M, Marmiroli N. Antimicrobial properties of antidepressants and Antipsychotics-Possibilities and implications. Pharmaceuticals (Basel). Sep 10 2021;14(9):915. doi:10.3390/ph14090915.
   PubMedGoogle Scholar
• Pluta K, Morak-Młodawska B, Jeleń M. Recent progress in biological activities of synthesized phenothiazines. Eur J Med Chem. 2011;46(8):3179–3189. doi:10.1016/j.ejmech.2011.05.013.
   PubMed Web of Science ®Google Scholar
• Thanacoody HK. Thioridazine: resurrection as an antimicrobial agent? Br J Clin Pharmacol. 2007;64(5):566–574. doi:10.1111/j.1365-2125.2007.03021.x.
   PubMed Web of Science ®Google Scholar
• Bansode TN, Shelke JV, Dongre VG. Synthesis and antimicrobial activity of some new N-acyl substituted phenothiazines. Eur J Med Chem. 2009;44(12):5094–5098. doi:10.1016/j.ejmech.2009.07.006.
   PubMed Web of Science ®Google Scholar
• Zajíčková M, Prchal L, Navrátilová M, et al. Sertraline as a new potential anthelmintic against haemonchus contortus: toxicity, efficacy, and biotransformation. Vet Res. 2021;52(1):143. doi:10.1186/s13567-021-01012-x.
   PubMed Web of Science ®Google Scholar
• Weeks JC, Roberts WM, Leasure C, et al. Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing. Sci Rep. Jan 17 2018;8(1):975. doi:10.1038/s41598-017-18457-w.
   PubMedGoogle Scholar
• Saraei M, Samadzadeh N, Khoeini J, et al. In vivo anti-Toxoplasma activity of aripiprazole. Iran J Basic Med Sci. 2015;18(9):938–941.
   PubMed Web of Science ®Google Scholar
• Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003;62(3):237–244. doi:10.1016/s0920-9964(02)00357-2.
   PubMed Web of Science ®Google Scholar
• Goodwin DG, Strobl JS, Lindsay DS. Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures. J Parasitol. 2011;97(1):148–151. doi:10.1645/GE-2536.1.
   PubMed Web of Science ®Google Scholar
• Fond G, Macgregor A, Tamouza R, et al. Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. Mar 2014;264(2):179–183. doi:10.1007/s00406-013-0413-4.
   PubMed Web of Science ®Google Scholar
• Dai F, Song JH, Hong YP, et al. Dopaminergic antagonists inhibit bile chemotaxis of adult Clonorchis sinensis and its egg production. PLoS Negl Trop Dis. 2020;14(3):e0008220. doi:10.1371/journal.pntd.0008220.
   PubMed Web of Science ®Google Scholar
• Sifontes-Rodríguez S, Mollineda-Diogo N, Monzote-Fidalgo L, et al. In vitro and in vivo antileishmanial activity of thioridazine. Acta Parasitol. 2023; Dec 9. Online ahead of print. doi:10.1007/s11686-023-00746-2.
   PubMed Web of Science ®Google Scholar
• Wu S, Mao G, Kirsebom LA. Inhibition of bacterial RNase P RNA by phenothiazine derivatives. Biomolecules. 2016;6(3):38. doi:10.3390/biom6030038.
   PubMed Web of Science ®Google Scholar
• Lieberman LA, Higgins DE. Inhibition of Listeria monocytogenes infection by neurological drugs. Int J Antimicrob Agents. 2010;35(3):292–296. doi:10.1016/j.ijantimicag.2009.10.011.
   PubMed Web of Science ®Google Scholar
• Lieberman LA, Higgins DE. A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection. Antimicrob Agents Chemother. 2009;53(2):756–764. doi:10.1128/AAC.00607-08.
   PubMed Web of Science ®Google Scholar
• Kumar S, Sandeep K, Kumar R, et al. Antimicrobial effect of pimozide by targeting ROS-mediated killing in Staphylococcus aureus. Biotechnol Appl Biochem. 2023;70(5):1679–1689 doi:10.1002/bab.2465.
   PubMed Web of Science ®Google Scholar
• Kristiansen MM, Leandro C, Ordway D, et al. Phenothiazines alter resistance of methicillin-resistant strains of Staphy­lococcus aureus (MRSA) to oxacillin in vitro. Int J Antimicrob Agents. 2003;22(3):250–253. doi:10.1016/s0924-8579(03)00200-0.
   PubMed Web of Science ®Google Scholar
• Kristiansen JE, Mortensen I. Antibacterial effect of four phenothiazines. Pharmacol Toxicol. 1987;60(2):100–103. doi:10.1111/j.1600-0773.1987.tb01504.x.
   PubMedGoogle Scholar
• Kristiansen JE. [Are chlorpromazine and other phenothiazines also antibiotics? Ugeskr Laeger. Jul 20 1981;143(30):1900–1904. Er klorpromazin og andre fenotiaziner tillige kemoterapeutika?
   PubMedGoogle Scholar
• Andersson JA, Fitts EC, Kirtley ML, et al. New role for FDA-Approved drugs in combating Antibiotic-Resistant bacteria. Antimicrob Agents Chemother. 2016;60(6):3717–3729. doi:10.1128/AAC.00326-16.
   PubMed Web of Science ®Google Scholar
• Chan YY, Ong YM, Chua KL. Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. Antimicrob Agents Chemother. 2007;51(2):623–630. doi:10.1128/AAC.01033-06.
   PubMed Web of Science ®Google Scholar
• Rajasekharan SK, Lee JH, Lee J. Aripiprazole repurposed as an inhibitor of biofilm formation and sterol biosynthesis in multidrug-resistant Candida albicans. Int J Antimicrob Agents. 2019;54(4):518–523. doi:10.1016/j.ijantimicag.2019.05.016.
   PubMed Web of Science ®Google Scholar
• Miron-Ocampo A, Beattie SR, Guin S, et al. CWHM-974 is a fluphenazine derivative with improved antifungal activity against Candida albicans due to reduced susceptibility to multidrug transporter-mediated resistance mechanisms. Antimicrob Agents Chemother. 2023;67(10):e0056723. doi:10.1128/aac.00567-23.
   PubMedGoogle Scholar
• Holbrook SYL, Garzan A, Dennis EK, et al. Repurposing antipsychotic drugs into antifungal agents: synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections. Eur J Med Chem. 2017;139:12–21. doi:10.1016/j.ejmech.2017.07.030.
   PubMed Web of Science ®Google Scholar
• Galgóczy L, Bácsi A, Homa M, et al. In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different candida species. Mycoses. 2011;54(6):e737-43–e743. Nov doi:10.1111/j.1439-0507.2010.02010.x.
   PubMed Web of Science ®Google Scholar
• Crespo-Facorro B, Ruiz-Veguilla M, Vazquez-Bourgon J, et al. Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis. Front Pharmacol. 2021;12:646701. doi:10.3389/fphar.2021.646701.
   PubMed Web of Science ®Google Scholar
• Ogundeji AO, Pohl CH, Sebolai OM. The repurposing of anti-Psychotic drugs, quetiapine and olanzapine, as anti-Cryptococcus drugs. Front Microbiol. 2017;8:815. doi:10.3389/fmicb.2017.00815.
   PubMed Web of Science ®Google Scholar
• Kristiansen JE, Vergmann B. The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria. Acta Pathol Microbiol Immunol Scand B. 1986;94(6):393–398. doi:10.1111/j.1699-0463.1986.tb03073.x.
   PubMedGoogle Scholar
• Kristiansen JE, Dastidar SG, Palchoudhuri S, et al. Phenothiazines as a solution for multidrug resistant tuberculosis: from the origin to present. Int Microbiol. 2015;18(1):1–12. doi:10.2436/20.1501.01.229.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Deshpande D, Sherman CM, et al. A ‘shock and awe’ thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease. J Antimicrob Chemother. 2017;72(suppl_2):i43–i47. doi:10.1093/jac/dkx308.
   PubMedGoogle Scholar
• Otręba M, Kośmider L, Rzepecka-Stojko A. Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review. Eur J Pharmacol. Nov 15 2020;887:173553. doi:10.1016/j.ejphar.2020.173553.
   PubMed Web of Science ®Google Scholar
• Lu J, Hou Y, Ge S, et al. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro. Life Sci. 2021;266:118889. doi:10.1016/j.lfs.2020.118889.
   PubMed Web of Science ®Google Scholar
• Liang T, Xiao S, Wu Z, et al. Phenothiazines inhibit SARS-CoV-2 entry through targeting spike protein. Viruses. 2023;15(8):1666. doi:10.3390/v15081666.
   PubMed Web of Science ®Google Scholar
• Hashizume M, Takashima A, Ono C, et al. Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1. Antiviral Res. 2023;209:105481. doi:10.1016/j.antiviral.2022.105481.
   PubMed Web of Science ®Google Scholar
• Girgis RR, Lieberman JA. Anti-viral properties of antipsychotic medications in the time of COVID-19. Psychiatry Res. 2021;295:113626. doi:10.1016/j.psychres.2020.113626.
   PubMed Web of Science ®Google Scholar
• Chamoun-Emanuelli AM, Pecheur EI, Simeon RL, et al. Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes. Antimicrob Agents Chemother. 2013;57(6):2571–2581. doi:10.1128/AAC.02593-12.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Quevedo J, Shahani L, et al. Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses. Braz J Psychiatry. 2021;43(5):462–464. doi:10.1590/1516-4446-2020-0024.
   PubMedGoogle Scholar
• Piccini LE, Castilla V, Damonte EB. Inhibition of dengue virus infection by trifluoperazine. Arch Virol. 2022;167(11):2203–2212. doi:10.1007/s00705-022-05555-y.
   PubMed Web of Science ®Google Scholar
• Huang J, Zhao D, Liu Z, et al. Repurposing psychiatric drugs as anti-cancer agents. Cancer Lett. 2018;419:257–265. doi:10.1016/j.canlet.2018.01.058.
   PubMed Web of Science ®Google Scholar
• Feldman SR. Advances in and hope for the treatment of parasitosis. J Dermatolog Treat. 2016;27(3):197–197. doi:10.3109/09546634.2016.1153254.
   PubMed Web of Science ®Google Scholar